WO2014066798A3 - Method and system for treating a disease using combined radiopharmaceuticals - Google Patents

Method and system for treating a disease using combined radiopharmaceuticals Download PDF

Info

Publication number
WO2014066798A3
WO2014066798A3 PCT/US2013/066872 US2013066872W WO2014066798A3 WO 2014066798 A3 WO2014066798 A3 WO 2014066798A3 US 2013066872 W US2013066872 W US 2013066872W WO 2014066798 A3 WO2014066798 A3 WO 2014066798A3
Authority
WO
WIPO (PCT)
Prior art keywords
patient
disease
treating
radiopharmaceuticals
combined
Prior art date
Application number
PCT/US2013/066872
Other languages
French (fr)
Other versions
WO2014066798A2 (en
Inventor
Robert Hobbs
George Sgouros
Richard L. Wahl
Original Assignee
The Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Johns Hopkins University filed Critical The Johns Hopkins University
Priority to EP13848483.7A priority Critical patent/EP2912610A4/en
Priority to US14/438,132 priority patent/US20150286796A1/en
Publication of WO2014066798A2 publication Critical patent/WO2014066798A2/en
Publication of WO2014066798A3 publication Critical patent/WO2014066798A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1069—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from blood cells, e.g. the cancer being a myeloma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Business, Economics & Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Strategic Management (AREA)
  • Human Resources & Organizations (AREA)
  • Chemical & Material Sciences (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Theoretical Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Quality & Reliability (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Business, Economics & Management (AREA)
  • Tourism & Hospitality (AREA)
  • Operations Research (AREA)
  • Marketing (AREA)
  • Economics (AREA)
  • Data Mining & Analysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Computing Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

A method and system of treating a disease for a patient, comprising assigning class data related to a class of patients that have characteristics similar to a specific patient and/or accessing patent data related to the specific patient; and optimizing a treatment plan, the optimizing being determined utilizing properties of a radiopharmaceutical used to treat the patient and the class data and/or the patient data.
PCT/US2013/066872 2009-05-14 2013-10-25 Method and system for treating a disease using combined radiopharmaceuticals WO2014066798A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP13848483.7A EP2912610A4 (en) 2012-10-26 2013-10-25 Method and system for treating a disease using combined radiopharmaceuticals
US14/438,132 US20150286796A1 (en) 2009-05-14 2013-10-25 Method and system for treating a disease using combined radiopharmaceuticals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261719283P 2012-10-26 2012-10-26
US61/719,283 2012-10-26

Publications (2)

Publication Number Publication Date
WO2014066798A2 WO2014066798A2 (en) 2014-05-01
WO2014066798A3 true WO2014066798A3 (en) 2014-06-26

Family

ID=50545495

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/066872 WO2014066798A2 (en) 2009-05-14 2013-10-25 Method and system for treating a disease using combined radiopharmaceuticals

Country Status (2)

Country Link
EP (1) EP2912610A4 (en)
WO (1) WO2014066798A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107832230B (en) * 2017-12-04 2021-01-01 中国工商银行股份有限公司 Test method, equipment and system based on data tuning

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020046010A1 (en) * 1998-04-21 2002-04-18 Bechtel Bwxt Idaho, Llc Methods and computer readable medium for improved radiotherapy dosimetry planning
US20060025824A1 (en) * 2004-05-12 2006-02-02 Freeman Gary A Automatic therapy advisor
US20060058966A1 (en) * 2004-09-15 2006-03-16 Bruckner Howard W Methods and systems for guiding selection of chemotherapeutic agents
US20090154644A1 (en) * 2007-12-12 2009-06-18 Varian Medical Systems International Ag Treatment planning system and method for radiotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7046762B2 (en) * 1999-11-05 2006-05-16 Georgia Tech Research Corporation Systems and methods for global optimization of treatment planning for external beam radiation therapy
US8812240B2 (en) * 2008-03-13 2014-08-19 Siemens Medical Solutions Usa, Inc. Dose distribution modeling by region from functional imaging
US8688618B2 (en) * 2009-06-23 2014-04-01 The Johns Hopkins University Method and system for determining treatment plans

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020046010A1 (en) * 1998-04-21 2002-04-18 Bechtel Bwxt Idaho, Llc Methods and computer readable medium for improved radiotherapy dosimetry planning
US20060025824A1 (en) * 2004-05-12 2006-02-02 Freeman Gary A Automatic therapy advisor
US20060058966A1 (en) * 2004-09-15 2006-03-16 Bruckner Howard W Methods and systems for guiding selection of chemotherapeutic agents
US20090154644A1 (en) * 2007-12-12 2009-06-18 Varian Medical Systems International Ag Treatment planning system and method for radiotherapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2912610A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107832230B (en) * 2017-12-04 2021-01-01 中国工商银行股份有限公司 Test method, equipment and system based on data tuning

Also Published As

Publication number Publication date
WO2014066798A2 (en) 2014-05-01
EP2912610A2 (en) 2015-09-02
EP2912610A4 (en) 2017-05-17

Similar Documents

Publication Publication Date Title
AU2018256508A1 (en) Individualized vaccines for cancer
IL276434A (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
IL279330A (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2012062925A3 (en) Compounds and methods for treating pain
WO2014089241A3 (en) Molecular profiling for cancer
PH12015501744A1 (en) Therapeutic and diagnostic target for cancer comprising dll3 binding reagents
PH12015500954B1 (en) Device for extracorporeal blood treatment
WO2014186453A3 (en) Apparatus and method for administering a medical device prescription
MX356755B (en) Fumigillol type compounds and methods of making and using same.
SI2852408T1 (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2013162981A3 (en) Breast implant spacers for the treatment of periprosthetic breast implant infections
WO2014066798A3 (en) Method and system for treating a disease using combined radiopharmaceuticals
WO2014043223A8 (en) Irhom2 inhibition for the treatment of complement mediated disorders
UA82691U (en) Method for treatment of abnormalities in consolidation of bone fractures
UA82673U (en) Method for treating impaired union of fracture

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13848483

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14438132

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2013848483

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13848483

Country of ref document: EP

Kind code of ref document: A2